|
|
Harborview Medical Center Guidelines
Sepsis: Early Goal Directed Therapy (EGDT)
Step 1: Is an infection suspected?
Step 2: Does the patient exhibit 2 or more of the following:
- Temperature > 38° C or < 36° C
- Heart rate > 90 beats/min.
- Respiratory rate > 20 breaths/min., PaCO2 < 32 or intubation for respiratory failure
- WBC count > 12,000/mm3, < 4000/mm3 or > 10% immature (band) forms
Step 3: If the answer is yes to step 1 & 2, proceed with this protocol.
Initial Resuscitation Period (First hour):
- Obtain serum lactate level STAT (venous or arterial in a blood gas syringe)
- CBC with differential STAT
- Obtain 2 sets of blood cultures prior to antibiotic administration (one set from a peripheral site)
- Administer antibiotics within 3 hours of ED presentation or 1 hour for in-patient presentation
(See pages 3 - 5 for antibiotic administration guidelines)
- Initiate fluid resuscitation with 20 mL/kg of:
- Normal Saline
- Lactated Ringers
Weight (estimated): ____________ kg x 20 mL = ____________ mL fluid bolus
- Repeat lactate level after fluid administration
If the repeat lactate level is ≥ 4 mmol/L OR the patient is hypotensive (MAP < 65 mmHg), initiate “Code Sepsis” by dialing 222.
- Initiate admission to the Intensive Care Unit
For persistent hypotension (MAP < 65 mmHg) or lactate ≥ 4 mmol/L after initial fluid bolus (First 6 hours):
- Fluid Resuscitation:
- If MAP < 65 mmHg or initial lactate > 4 mmol/L, administer additional 500 mL fluid bolus.
- When central is placed, transduce Central Venous Pressure (CVP) with goal: < 8 mmHg (if not mechanically ventilated) or < 12 mmHg (if mechanically ventilated).
- Repeat assessment for fluid bolus every 30 minutes
Note : If signs of intravascular volume excess develop (JVD, crackles, or SpO2 drop by more than 5% points) stop fluid boluses and notify MD.
- Central Intravenous Access:
- Oximetric ScvO2 catheter and measure CVP and ScvO2
OR
- Central venous catheter and measure central venous pressure
- Obtain mixed venous oxygen saturation
- If ScvO2 is < 70% and CVP < 8 – 12 mmHg, return to #1 and administer fluids
- Repeat lactate & mixed venous oxygen levels a minimum of every 2 hours & after interventions.
- Vasopressor Support:
For hypotension not responding to repeat fluid boluses (MAP ≥ 65 mm Hg or SBP ≥ 90 mm Hg), start:
- Norepinephrine – Start infusion at 5 mcg/min; titrate up by doubling dose every 5 min.
If dose exceeds 30 mcg/min, notify MD.
- Dopamine – Start infusion at 2 mcg/kg/min; titrate up by 2.5 mcg/kg/min every 5 min.
If dose exceeds 20 mcg/kg/min, tachycardia worsens or ventricular ectopy develops, notify MD.
- Vasopressin – Start infusion at 0.04 units/min; utilize as a second line agent in addition to Norepinephrine or Dopamine. Do not titrate.
- Additional Support:
- If ScvO2 is < 70% and CVP > 8 – 12 mmHg and Hct > 30%, start Dobutamine at 5 mcg/kg/min. Increase dose by 2.5 mcg/kg/min every 15 minutes if ScvO2 < 70%. Maximum dose 20 mcg/kg/min. Decrease dose if MAP < 65 mmHg or heart rate > 120 bpm.
- If ScvO2 is < 70% and Hct < 30%, give PRBC
(consider potential sources of blood loss)
- Insert arterial pressure line
- Evaluate for Drotrecogin (Xigris) using Drotrecogin (Xigris) orders.
Initial Empiric Antimicrobial Therapy in Sepsis
Based on Suspected Primary Source
Principles:
- Recommendations are for septic patients requiring critical care, not uncomplicated infections
- Review past microbiology for known colonization with resistant organisms
- Broad empiric coverage based on local microbiology and antimicrobial resistance patterns
- De-escalate (narrow coverage) once cultures and susceptibilities available
- Consult with pharmacy for renal dosing adjustment if CrCl < 50 mL/min or creatinine > 1.2
Allergies: ______________________________________________________________
1. Sepsis: site unknown
(MRSA, Resistant Gram-negative bacilli)
- Vancomycin ________ Gram (15 mg/kg) IV every 12 hours
PLUS
- Imipenem 500 mg IV every 6 hours
If previous colonization or concerns for highly resistant Gram-negative pathogen such as Acinetobacter, Pseudomonas, or ESBL, consider addition of:
- Amikacin ________ mg (7.5 mg/kg) IV every 12 hours
OR
- Ciprofloxacin 400 mg IV every 12 hours (if renal impairment)
2. Pneumonia
A. Community-acquired, non-aspiration risk (MRSA, S. pneumonia, Legionella)
- Vancomycin ________ Gram (15 mg/kg) IV every 12 hours
OR
- Linezolid 600 mg IV every 12 hours or Linezolid 600 mg PO every 12 hours
PLUS
- Ceftriaxone 1 Gram IV every 24 hours
PLUS
- Azithromycin 500 mg IV every 24 hours
If aspiration risk:
- Ampicillin-sulbactam 3 Grams IV every 6 hours (to replace Ceftriaxone)
B. Healthcare-associated (MRSA, Gram-negative bacilli)
(Skilled Nursing Facility or hospital non-ICU, not known to be colonized with Acinetobacter)
- Vancomycin ________ Gram (15 mg/kg) IV every 12 hours
OR
- Linezolid 600 mg IV every 12 hours or Linezolid 600 mg PO every 12 hours
PLUS
- Piperacillin-tazobactam 4.5 Grams IV every 6 hours
C. Late-onset ventilator-associated (> 4 days of MV or hospitalization)
(MRSA, Resistant Gram-negative bacilli including Acinetobacter, Pseudomonas, ESBL)
- Vancomycin ________ Gram (15 mg/kg) IV every 12 hours
OR
- Linezolid 600 mg IV every 12 hour or Linezolid 600 mg PO every 12 hour
PLUS
- Imipenem 500 mg IV every 6 hours
If previous colonization or concern for highly resistant Gram-negative pathogen such as Acinetobacter, consider addition of:
- Amikacin ________ mg (7.5 mg/kg) IV every 12 hours
OR
- Ciprofloxacin 400 mg IV every 12 hours (if renal impairment)
3. Bloodstream
A. Community (Injection drug use) or Hemodialysis; (MRSA, Gram-negative bacilli)
- Vancomycin ________ Gram (15 mg/kg) IV every 12 hours
PLUS
- Gentamicin ________ mg (5 mg/kg) IV every 24 hours
OR
- Gentamicin ________ mg (1 mg/kg) every 48 hours after hemodialysis
B. Hospital-acquired, Gram stain available
Gram positive awaiting culture identification:
- Vancomycin ________ Gram (15 mg/kg) IV every 12 hours
Gram-negative awaiting culture identification:
- □ Imipenem 500 mg IV every 6 hours
4. Necrotizing Skin and Soft Tissue Infection
(MRSA, Group A strep, Clostridium sp and mixed anaerobes, Gram-negative bacilli)
- Vancomycin ________ Gram (15 mg/kg) IV every 12 hours
PLUS
- Penicillin 4 million units IV every 4 hours
PLUS
- Clindamycin 1200 mg IV every 6 hours
PLUS
- Gentamicin ________ mg (5 mg/kg) IV every 24 hours
If renal impairment:
OR
- Ciprofloxacin 400 mg IV every 12 hours (to replace Gentamicin)
5. Intra-abdominal
A. Community (Enteric Gram-negative bacilli, anaerobes)
- Ampicillin-sulbactam 3 Grams IV every 6 hours
B. Hospital-acquired (Resistant Gram-negative bacilli, anaerobes)
- Piperacillin-tazobactam 3.375 Grams IV every 6 hours
OR
- Imipenem 500 mg IV every 6 hours
If GPC in clusters on gram stain or concern for MRSA,
add
- Vancomycin ________ Gram (15 mg/kg) IV every 12 hours
6. Neutropenic fever (oncology patients) and sepsis
(MRSA, Resistant Gram-negative bacilli including Acinetobacter, Pseudomonas, ESBL)
- Vancomycin ________ Gram (15 mg/kg) IV every 12 hours
PLUS
- Imipenem 500 mg IV every 6 hours
PLUS
- Amikacin ________ mg (7.5 mg/kg) IV every 12 hours
OR If renal impairment:
- Ciprofloxacin 400 mg IV every 12 hours (to replace Amikacin)
Empiric therapy with micafungin for suspected candidemia should be considered in septic patients with any of the following risk factors: total parenteral nutrition, prolonged broad-spectrum antibiotics, hematologic malignancy or transplant, femoral catheterization, or Candida colonization at multiple sites.
- Micafungin 100 mg IV every 24 hours
Additional Orders:
______________________________________________________________________________________
Top of Page
Read also: Sepsis: Initial Resuscitation Orders
(For adult patients only)
|